$ 673.91
Details
The test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. The simple urine sample collection also allows for improved patient comfort. Because tumor markers can be used to assess the response of a tumor treatment and for prognosis, rapid screening tests like the Status BTA product are very helpful in the treatment management of cancer patients.CLIA WaivedResults available in 5 minutesSimple procedure requires only adding 3 drops of urine to test device; no sample preparation neededAccurate test results with excellent sensitivity and specificityUses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urineDetects early state recurrance cancer that cytology may missAdjunct test to cystoscopyThe test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. The simple urine sample collection also allows for improved patient comfort. Because tumor markers can be used to assess the response of a tumor treatment and for prognosis, rapid screening tests like the Status BTA product are very helpful in the treatment management of cancer patients.CLIA WaivedResults available in 5 minutesSimple procedure requires only adding 3 drops of urine to test device; no sample preparation neededAccurate test results with excellent sensitivity and specificityUses monoclonal antibodies to detect the presence of bladder tumor associated antigen in urineDetects early state recurrance cancer that cytology may missAdjunct test to cystoscopy
